FSC
AZN icon

Full Sail Capital’s AstraZeneca AZN Stock Holding History

Full Sail Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,485
Closed -$231K – 160
2024
Q3 		$231K Sell
1,485
-802
-35% -$129K 0.01% 149
2024
Q2 		$357K Buy
2,287
+25
+1% +$3.76K 0.02% 139
2024
Q1 		$307K Sell
2,262
-1,275
-36% -$169K 0.02% 143
2023
Q4 		$476K Sell
3,537
-935
-21% -$122K 0.04% 119
2023
Q3 		$606K Buy
4,472
+16
+0.4% +$2.19K 0.05% 98
2023
Q2 		$638K Hold
4,456
– – 0.05% 100
2023
Q1 		$619K Buy
4,456
+28
+0.6% +$3.77K 0.06% 93
2022
Q4 		$600K Sell
4,428
-158
-3% -$19.8K 0.06% 95
2022
Q3 		$503K Sell
4,586
-131
-3% -$16.6K 0.05% 92
2022
Q2 		$623K Hold
4,717
– – 0.06% 90
2022
Q1 		$626K Sell
4,717
-31
-0.7% -$3.72K 0.05% 97
2021
Q4 		$549K Hold
4,748
– – 0.05% 99
2021
Q3 		$571K Hold
4,748
– – 0.05% 99
2021
Q2 		$569K Sell
4,748
-1,713
-27% -$188K 0.05% 98
2021
Q1 		$636K Hold
6,461
– – 0.06% 94
2020
Q4 		$704K Buy
6,461
+190
+3% +$20.1K 0.08% 89
2020
Q3 		$692K Sell
6,271
-190
-3% -$21.1K 0.09% 81
2020
Q2 		$716K Hold
6,461
– – 0.1% 84
2020
Q1 		$688K Sell
6,461
-89
-1% -$8.38K 0.12% 83
2019
Q4 		$650K Sell
6,550
-23
-0.3% -$2.17K 0.14% 84
2019
Q3 		$629K Sell
6,573
-8
-0.1% -$694 0.15% 82
2019
Q2 		$589K Sell
6,581
-15
-0.2% -$1.18K 0.17% 78
2019
Q1 		$533K Buy
+6,596
New +$520K 0.17% 77

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Full Sail Capital's AZN Position: Q4 2024 in Review

Full Sail Capital sold out of AstraZeneca (AZN) in Q4 2024, closing a stake of 1,485 shares — an estimated $231K sold.

Full Sail Capital first reported a position in AZN in Q1 2019 and held it in 23 quarters. The position peaked at $716K in Q2 2020. 1,220 funds tracked by Wall St. Rank hold AZN as of Q4 2024.

  • Full Sail Capital reported no remaining AstraZeneca position as of Q4 2024 after selling out during the quarter.
  • Full Sail Capital sold 1,485 AstraZeneca shares in Q4 2024, an estimated $231K.
  • Full Sail Capital first reported a position in AstraZeneca in Q1 2019 and held it in 23 quarters.
  • Full Sail Capital's AstraZeneca position peaked at $716K in Q2 2020.
  • 1,220 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2024.

Based on Full Sail Capital's 13F filing for Q4 2024, filed 14 Feb 2025.